Patients

Millions Still Waiting for Breakthroughs Against Neglected Diseases

By December 20, 2012 July 7th, 2014 No Comments

Over the past decade, only 3.8% of newly approved drugs have been created for neglected diseases.  These include tuberculosis, tropical and other diseases that often have ineffective or outdated treatment options, and make up 10.5% of diseases worldwide.

Read more here

J. Lewis Research, Inc.

J. Lewis Research, Inc.

We are a unique research company in Salt Lake City with over 25 years of experience conducting clinical trials for the pharmaceutical industry, specializing in Phase II, III and IV clinical trials.